Psychedelic Stocks

2020-11-24 PSW Editor

MindMed launches its digital medical division.

2020-11-24 Jeff Nielson

ATAI Life Sciences is going public. MindMed Inc is hitting new highs. The two events ARE connected.

2020-11-23 PSW Editor

Novamind has closed on double its original target (CAD$5 million). Preparing to commence trading on the CSE (symbol "NM").

2020-11-20 Jeff Nielson

What's the best "investment advice" that any of us could receive in 2020? Invest in Small Business.

2020-11-19 PSW Editor

Field Trip announces a new clinics-based research program, beginning with psychedelic therapies for military veterans.

2020-11-19 PSW Editor

Including its new financing, Mind Cure currently has in excess of CAD$5 million in cash.

2020-11-18 PSW Editor

Delic Corp is a Delaware-based psychedelics company that has gone public via RTO.

2020-11-18 PSW Editor

Numinus plans a "compassionate access" clinical trial of psilocybin to treat substance abuse.

2020-11-18 Jeff Nielson

Will psychedelic drug therapies (simultaneously) save lives as they cure mental health disorders?

2020-11-17 PSW Editor

Mind Cure's new CSO is a decorated researcher, entrepreneur and inventor.

2020-11-17 PSW Editor

Field Trip is entering the (already legal) Netherlands psilocybin market with a "Field Trip Health Center" in Amsterdam.

2020-11-17 PSW Editor

Mydecine provides an update on its Phase 2A clinical trial of psilocybin-assisted psychotherapy for the treatment of PTSD.